Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Inadequate eating habits, such as excessive caloric intake and diets high in saturated fats, are associated with the development of obesity and intestinal alterations. Green coffee is rich in bioactive antioxidant compounds, which may assist in obesity management. This study aimed to evaluate the effect of aqueous green coffee extract on intestinal health in Wistar rats fed a high-fat diet. The four experimental groups ( = 8) were: CT (control diet), HF (high-fat diet), HFP (prevention experimental group - high-fat diet with extract supplementation from the first experimental week), and HFT (treatment experimental group - high-fat diet with extract supplementation starting from the 8th week). Compared to the CT group, the HF group exhibited a significant reduction ( < 0.05) in intestinal pH, NO, and SOD levels, as well as in the morphometric parameters of the intestinal mucosa and the quantification of TJ proteins - claudin and occludin. In contrast, preventive supplementation with GCE (HFP group) effectively preserved intestinal mucosal integrity and maintained claudin and occludin. On the other hand, therapeutic supplementation (HFT) reduced the intestinal pH, increased butyrate and acetate levels, recovered the mucosal morphometric parameters, and enhanced the quantification of claudin and occludin. The HFP group showed an increase in Bacteroidetes and Verrucomicrobia and a reduction in Firmicutes. The high-fat diet reduced species richness and diversity and GCE was not able to reverse this. These findings demonstrate the beneficial effects of aqueous green coffee extract on intestinal health, highlighting its potential as a strategy for preventing and treating intestinal alterations induced by a high-fat diet.

Download full-text PDF

Source
http://dx.doi.org/10.1039/d5fo02228bDOI Listing

Publication Analysis

Top Keywords

high-fat diet
24
green coffee
16
aqueous green
12
coffee extract
12
extract intestinal
12
intestinal health
12
claudin occludin
12
intestinal
9
health wistar
8
wistar rats
8

Similar Publications

Hepatocyte apoptosis is a key feature of metabolic dysfunction-associated steatohepatitis (MASH), but the fate of apoptotic hepatocytes in MASH is poorly understood. Here, we explore the hypotheses that clearance of dead hepatocytes by liver macrophages (efferocytosis) is impaired in MASH because of low expression of the efferocytosis receptor T cell immunoglobulin and mucin domain containing 4 (TIM4; gene ) by MASH liver macrophages, which then drives liver fibrosis in MASH. We show that apoptotic hepatocytes accumulate in human and experimental MASH, using mice fed the fructose-palmitate-cholesterol (FPC) diet or the high-fat, choline-deficient amino acid-defined (HF-CDAA) diet.

View Article and Find Full Text PDF

Hepatic ischaemia-reperfusion (IR) injury is a serious clinical issue, especially in patients with type 2 diabetes mellitus (T2DM). As mitochondria play a critical role in the regulation of IR-induced liver damage, mitochondria-targeted treatment is of the utmost significance for improving outcomes. The present study explored the mitoprotective role of combined ginsenoside-MC1 (GMC1) and irisin administration in diabetic rats with hepatic IR injury.

View Article and Find Full Text PDF

Hyperlipidemia is a common chronic disease characterized by elevated levels of lipids in the blood. There is some evidence that suggests that berberine (BBR) might be beneficial for the treatment of hyperlipidemia. However, its low intestinal bioavailability limits its potential therapeutic action.

View Article and Find Full Text PDF

Kinases are activators of well‑known inflammatory cascades implicated in metabolic disorders, and abnormal activation of casein kinase II (CK2) is associated with several inflammatory disorders. However, thus far, its role in the low‑grade chronic inflammatory response known as 'metaflammation', which is a hallmark of obesity and type 2 diabetes, has not yet been elucidated. The present study aimed to evaluate the role of CK2 in diet‑induced metaflammation and the effects of the CK2 inhibitor 4,5,6,7‑tetrabromobenzotriazole (TBB) on a murine model fed a high‑fat‑high‑sugar (HFHS) diet.

View Article and Find Full Text PDF

Purpose: CL316,243 (CL), a beta 3 adrenergic receptor (B3-AR) agonist has 'exercise mimetic' effects in adipose tissue (AT). CL may also positively affect skeletal muscle (SM), yet the role of estrogen receptor beta (ERβ) in mediating SM-specific effects of CL is not known. We investigated the effects of CL on SM metabolism, as well as the role played by ERβ.

View Article and Find Full Text PDF